Seattle, WA, United States of America

Linda Zuckerman

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Linda Zuckerman: Pioneering Innovations in Wound Therapy and Autoimmune Treatments

Introduction

Linda Zuckerman, an accomplished inventor based in Seattle, Washington, has made significant contributions to the fields of medicine and immunology through her innovative patents. With a total of two patents to her name, Zuckerman has been at the forefront of developing groundbreaking therapies aimed at improving patient outcomes.

Latest Patents

Zuckerman's latest patents showcase her expertise in formulating novel therapeutic solutions. The first patent focuses on "Formulations for Wound Therapy," detailing a dry powder fibrin sealant made from a mixture of fibrinogen and/or thrombin. This invention is particularly aimed at treating wounds or injuries, serving as a topical hemostatic composition or aiding in surgical interventions.

Her second patent addresses autoimmune diseases through the "Combination of BLyS and/or APRIL Inhibition and Immunosuppressants for Treatment." This invention outlines novel combination therapies that involve BLyS or BLyS/APRIL inhibition alongside immunosuppressants, providing new avenues for treating autoimmune conditions. Notably, this method includes Fc-fusion proteins such as TACI-Fc, BAFF-R-Fc, and BCMA-Fc, as well as drugs that suppress the immune system, including cyclophosphamide and azathioprine.

Career Highlights

Throughout her career, Linda Zuckerman has held positions in reputable companies that emphasize research and development. Notably, she has worked at Mallinckrodt Pharma IP Trading, where her innovations contributed to advancing pharmaceutical formulations, and Zymogenetics, Inc., a leader in the biotechnology sector focused on creating novel therapeutic products.

Collaborations

Zuckerman’s collaborations have also played a crucial role in her development as an inventor. She has worked closely with notable colleagues such as Eliane Schutte and Richard I. Senderoff, bringing together a diverse range of expertise to further enhance the impact of her research.

Conclusion

Linda Zuckerman’s contributions to medical innovation demonstrate her commitment to improving therapeutic options for patients with wounds and autoimmune diseases. Her pioneering patents reflect a blend of scientific rigor and creativity, positioning her as a noteworthy figure in the patent landscape of medical inventions. As healthcare continues to evolve, Zuckerman’s work will undoubtedly help shape the future of treatment protocols in these critical areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…